We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreWe've prepared an analysis of the top 10 most expensive drugs in the US compared with Germany, in th...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreWe summarise the ISPOR Europe 2022 conference including plenary sessions on HTA, patient-centered re...
Read moreWe compare the rates of positive reimbursement decisions in England and EU4 for orphan drugs approve...
Read moreThis updated bill contains some similar measures to those proposed in March as well as some addition...
Read moreEUCOPE notes that “while these proposals don’t necessarily represent the final options included ...
Read moreThe paper examines potential reforms to current policies and practices related to orphan drug develo...
Read moreThe study, compiled by IQVIA, covers 160 drugs, including 41 oncology drugs and 57 orphan drugs whic...
Read moreThe amendment includes a number of articles which aims to “streamline the negotiation of the price...
Read more